Glasgow 2016 Podcast

HIV Glasgow_Podcast_Theme_v1 


About the Program:

Program Overview:

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the HIV Glasgow Drug Therapy Congress (HIV Glasgow 2016). This program consists of three components: (1) CME Internet Conference Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters from HIV Glasgow 2016, selected by the expert faculty discussants; (2) Rapid-Fire Review of HIV Glasgow 2016: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (3) From Conference to Clinic: Reviewing and Applying Data of HIV Drug Therapy/Glasgow 2016: case-based clinic meetings during which the key data are reviewed, discussed and applied to patient care.


The Rapid-Fire Review of HIV Glasgow 2016 features our national faculty panel briefly reviewing the most essential information and data from HIV Glasgow 2016. This activity will enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care.


All online components of the program can be accessed at


This program is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. in collaboration with Postgraduate Institute for Medicine. It is not a session created by or presented at HIV Glasgow 2016 and it is not sanctioned by the organizers of HIV Glasgow 2016.

Back to Top

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Learning Objectives:

After completing this activity, the participant should be better able to:

  • Use in a clinical setting findings from key new studies on HIV/AIDS diagnosis, management and treatment presented at HIV Glasgow 2016 

  • Employ the current treatment paradigms in the EU and US for HIV/AIDS, including those supported by studies and data presented at HIV Glasgow 2016, to improve patient care

  • Discuss with patients and colleagues the studies and data on newer therapies for HIV/AIDS presented at HIV Glasgow 2016 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS

  • Discuss application of new guidelines presented at HIV Glasgow 2016 to develop treatment plans that are specific to individual patient needs

Release Date: November 4, 2016

Expiration Date: November 4, 2017

Estimated time to complete the Podcast: 1 hour

Media: Internet

Back to Top


José Arribas, MD 
Research Director
(AIDS and Infectious Diseases)
Hospital de La Paz
Madrid, Spain

Marta Boffito, MD, PhD
St. Stephen's AIDS Trust and Imperial College
Chelsea and Westminster Hospital
London, United Kingdom

Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom

Jürgen Rockstroh, MD
Professor of Medicine
Department of Medicine I
University Hospital
Bonn, Germany

Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Back to Top

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Back to Top

Credit Designation:

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

European Continuous Medical Education Credit:

AMA PRA Category 1 Credit(s)™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credit(s)™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit(s)™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 1.0 ECMEC© Credits are available.

Back to Top

Disclosure of Conflicts of Interest:

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Jose Arribas, MD:

  • Consulting Fees: Merek, Gilead
  • Speakers' bureaus: ViiV, Janssen, AbbVie, BMS, Gilead, MSD

Marta Boffito, MD:

  • Consulting Fees: Gilead, BMS, ViiV
  • Contracted Research: Gilead, Janssen, ViiV, BMS
  • Speakers' bureaus: Gilead, Janssen, ViiV, BMS

Graeme Moyle, MD:

  • Consulting Fees: Tobira Therapeutics, Gilead, Merck
  • Speakers' bureaus: Merck, Gilead, BMS
  • Contracted Research: Merck, Gilead, ViiV
  • Ownership interest: Tobira

Juergen Rockstroh, MD:

  • Consulting Fees: Abbott, AbbVie, BMS, Cipla, Gilead, Janssen, Merck, ViiV
  • Contacted Research: Gilead

Renslow Sherer, MD:

  • Consulting Fees: Gilead
  • Contacted Research: Janssen, Gilead

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content:, Judi Smelker-Mitchek, RN, BSN; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP and Jan Shultz, RN, MSN, CHCP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.

Back to Top

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planner. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Back to Top

Instructions for Participation and Credit:

There are no fees for participating and receiving CME credit for this activity. During the period, November 4, 2016 through November 4, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course 11833.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year. 

Back to Top


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Back to Top

PIM_small       Annenberg Logo

VE logo 300px 

  This activity is supported by an independent educational grant from ViiV Healthcare.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.

Prepare to print

Share this page:

Get link code to this page                     

Back to Top